nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0207	0.0281	CbGbCtD
Tamoxifen—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0166	0.0224	CbGbCtD
Tamoxifen—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0145	0.0197	CbGbCtD
Tamoxifen—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0145	0.0197	CbGbCtD
Tamoxifen—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0145	0.0197	CbGbCtD
Tamoxifen—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0143	0.0194	CbGbCtD
Tamoxifen—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0136	0.0184	CbGbCtD
Tamoxifen—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0135	0.0183	CbGbCtD
Tamoxifen—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0135	0.0183	CbGbCtD
Tamoxifen—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0131	0.0178	CbGbCtD
Tamoxifen—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0131	0.0178	CbGbCtD
Tamoxifen—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0128	0.0174	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0128	0.0174	CbGbCtD
Tamoxifen—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0126	0.0171	CbGbCtD
Tamoxifen—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0122	0.0165	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0111	0.015	CbGbCtD
Tamoxifen—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0111	0.015	CbGbCtD
Tamoxifen—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0108	0.0146	CbGbCtD
Tamoxifen—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0145	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0145	CbGbCtD
Tamoxifen—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0106	0.0144	CbGbCtD
Tamoxifen—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0102	0.0139	CbGbCtD
Tamoxifen—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00975	0.0132	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00971	0.0132	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00971	0.0132	CbGbCtD
Tamoxifen—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00971	0.0132	CbGbCtD
Tamoxifen—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00971	0.0132	CbGbCtD
Tamoxifen—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00961	0.013	CbGbCtD
Tamoxifen—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00961	0.013	CbGbCtD
Tamoxifen—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.00937	0.0127	CbGbCtD
Tamoxifen—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00925	0.0125	CbGbCtD
Tamoxifen—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00924	0.0125	CbGbCtD
Tamoxifen—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00924	0.0125	CbGbCtD
Tamoxifen—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00912	0.0124	CbGbCtD
Tamoxifen—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00857	0.0116	CbGbCtD
Tamoxifen—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00841	0.0114	CbGbCtD
Tamoxifen—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0083	0.0112	CbGbCtD
Tamoxifen—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00805	0.0109	CbGbCtD
Tamoxifen—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.00791	0.0107	CbGbCtD
Tamoxifen—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.00791	0.0107	CbGbCtD
Tamoxifen—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00775	0.0105	CbGbCtD
Tamoxifen—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00775	0.0105	CbGbCtD
Tamoxifen—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00758	0.0103	CbGbCtD
Tamoxifen—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00728	0.00987	CbGbCtD
Tamoxifen—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00728	0.00987	CbGbCtD
Tamoxifen—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00715	0.00969	CbGbCtD
Tamoxifen—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00713	0.00966	CbGbCtD
Tamoxifen—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00713	0.00966	CbGbCtD
Tamoxifen—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.007	0.00949	CbGbCtD
Tamoxifen—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.007	0.00949	CbGbCtD
Tamoxifen—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00693	0.00939	CbGbCtD
Tamoxifen—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00692	0.00937	CbGbCtD
Tamoxifen—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00671	0.0091	CbGbCtD
Tamoxifen—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00669	0.00907	CbGbCtD
Tamoxifen—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00652	0.00883	CbGbCtD
Tamoxifen—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00652	0.00883	CbGbCtD
Tamoxifen—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0065	0.0088	CbGbCtD
Tamoxifen—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00644	0.00873	CbGbCtD
Tamoxifen—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00644	0.00873	CbGbCtD
Tamoxifen—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00625	0.00847	CbGbCtD
Tamoxifen—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00599	0.00812	CbGbCtD
Tamoxifen—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00589	0.00799	CbGbCtD
Tamoxifen—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00589	0.00799	CbGbCtD
Tamoxifen—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00587	0.00796	CbGbCtD
Tamoxifen—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00587	0.00796	CbGbCtD
Tamoxifen—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00563	0.00763	CbGbCtD
Tamoxifen—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00556	0.00754	CbGbCtD
Tamoxifen—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00542	0.00734	CbGbCtD
Tamoxifen—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0054	0.00732	CbGbCtD
Tamoxifen—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0054	0.00732	CbGbCtD
Tamoxifen—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00524	0.0071	CbGbCtD
Tamoxifen—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00509	0.00689	CbGbCtD
Tamoxifen—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00494	0.00669	CbGbCtD
Tamoxifen—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00488	0.00662	CbGbCtD
Tamoxifen—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00488	0.00662	CbGbCtD
Tamoxifen—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00474	0.00642	CbGbCtD
Tamoxifen—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00474	0.00642	CbGbCtD
Tamoxifen—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00468	0.00634	CbGbCtD
Tamoxifen—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00454	0.00616	CbGbCtD
Tamoxifen—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00447	0.00605	CbGbCtD
Tamoxifen—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00447	0.00605	CbGbCtD
Tamoxifen—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00441	0.00597	CbGbCtD
Tamoxifen—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00414	0.00561	CbGbCtD
Tamoxifen—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00414	0.00561	CbGbCtD
Tamoxifen—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00375	0.00508	CbGbCtD
Tamoxifen—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00375	0.00508	CbGbCtD
Tamoxifen—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00352	0.00476	CbGbCtD
Tamoxifen—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00323	0.00438	CbGbCtD
Tamoxifen—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00314	0.00426	CbGbCtD
Tamoxifen—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00284	0.00385	CbGbCtD
Tamoxifen—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00284	0.00385	CbGbCtD
Tamoxifen—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00272	0.00369	CbGbCtD
Tamoxifen—CYP19A1—semen—acquired immunodeficiency syndrome	0.00237	0.0329	CbGeAlD
Tamoxifen—UGT1A4—blood plasma—acquired immunodeficiency syndrome	0.00228	0.0316	CbGeAlD
Tamoxifen—EBPL—lung—acquired immunodeficiency syndrome	0.00105	0.0146	CbGeAlD
Tamoxifen—DHCR7—retina—acquired immunodeficiency syndrome	0.00102	0.0141	CbGeAlD
Tamoxifen—SULT1A1—digestive system—acquired immunodeficiency syndrome	0.001	0.0139	CbGeAlD
Tamoxifen—EBPL—nervous system—acquired immunodeficiency syndrome	0.000976	0.0136	CbGeAlD
Tamoxifen—SULT1A1—blood—acquired immunodeficiency syndrome	0.000955	0.0133	CbGeAlD
Tamoxifen—EBPL—central nervous system—acquired immunodeficiency syndrome	0.00094	0.0131	CbGeAlD
Tamoxifen—SULT1A1—spinal cord—acquired immunodeficiency syndrome	0.000921	0.0128	CbGeAlD
Tamoxifen—DHCR7—skin of body—acquired immunodeficiency syndrome	0.000892	0.0124	CbGeAlD
Tamoxifen—SULT1A1—vagina—acquired immunodeficiency syndrome	0.000886	0.0123	CbGeAlD
Tamoxifen—UGT1A4—digestive system—acquired immunodeficiency syndrome	0.000875	0.0122	CbGeAlD
Tamoxifen—SULT1A1—lung—acquired immunodeficiency syndrome	0.000838	0.0116	CbGeAlD
Tamoxifen—UGT1A4—blood—acquired immunodeficiency syndrome	0.000834	0.0116	CbGeAlD
Tamoxifen—SULT1A1—nervous system—acquired immunodeficiency syndrome	0.000776	0.0108	CbGeAlD
Tamoxifen—SULT1A1—central nervous system—acquired immunodeficiency syndrome	0.000747	0.0104	CbGeAlD
Tamoxifen—EBPL—brain—acquired immunodeficiency syndrome	0.000746	0.0104	CbGeAlD
Tamoxifen—DHCR7—lymphoid tissue—acquired immunodeficiency syndrome	0.000722	0.01	CbGeAlD
Tamoxifen—EBPL—lymph node—acquired immunodeficiency syndrome	0.000721	0.01	CbGeAlD
Tamoxifen—DHCR7—digestive system—acquired immunodeficiency syndrome	0.000713	0.00991	CbGeAlD
Tamoxifen—FMO1—digestive system—acquired immunodeficiency syndrome	0.000713	0.00991	CbGeAlD
Tamoxifen—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000708	0.00984	CbGeAlD
Tamoxifen—ESRRA—digestive system—acquired immunodeficiency syndrome	0.000702	0.00976	CbGeAlD
Tamoxifen—DHCR7—blood—acquired immunodeficiency syndrome	0.00068	0.00944	CbGeAlD
Tamoxifen—ESRRA—blood—acquired immunodeficiency syndrome	0.000669	0.00929	CbGeAlD
Tamoxifen—DHCR7—bone marrow—acquired immunodeficiency syndrome	0.000658	0.00914	CbGeAlD
Tamoxifen—DHCR7—spinal cord—acquired immunodeficiency syndrome	0.000655	0.0091	CbGeAlD
Tamoxifen—ESRRA—bone marrow—acquired immunodeficiency syndrome	0.000647	0.00899	CbGeAlD
Tamoxifen—ESRRA—spinal cord—acquired immunodeficiency syndrome	0.000645	0.00895	CbGeAlD
Tamoxifen—DHCR7—vagina—acquired immunodeficiency syndrome	0.00063	0.00875	CbGeAlD
Tamoxifen—FMO1—vagina—acquired immunodeficiency syndrome	0.00063	0.00875	CbGeAlD
Tamoxifen—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000624	0.00866	CbGeAlD
Tamoxifen—ESRRA—vagina—acquired immunodeficiency syndrome	0.00062	0.00862	CbGeAlD
Tamoxifen—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000618	0.00859	CbGeAlD
Tamoxifen—DHCR7—lung—acquired immunodeficiency syndrome	0.000596	0.00828	CbGeAlD
Tamoxifen—FMO1—lung—acquired immunodeficiency syndrome	0.000596	0.00828	CbGeAlD
Tamoxifen—SULT1A1—brain—acquired immunodeficiency syndrome	0.000593	0.00824	CbGeAlD
Tamoxifen—ESRRA—lung—acquired immunodeficiency syndrome	0.000586	0.00815	CbGeAlD
Tamoxifen—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000579	0.00804	CbGeAlD
Tamoxifen—SULT1A1—lymph node—acquired immunodeficiency syndrome	0.000573	0.00796	CbGeAlD
Tamoxifen—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000558	0.00775	CbGeAlD
Tamoxifen—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000555	0.00771	CbGeAlD
Tamoxifen—DHCR7—nervous system—acquired immunodeficiency syndrome	0.000552	0.00766	CbGeAlD
Tamoxifen—FMO1—nervous system—acquired immunodeficiency syndrome	0.000552	0.00766	CbGeAlD
Tamoxifen—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000549	0.00763	CbGeAlD
Tamoxifen—FMO3—vagina—acquired immunodeficiency syndrome	0.000544	0.00756	CbGeAlD
Tamoxifen—ESRRA—nervous system—acquired immunodeficiency syndrome	0.000543	0.00755	CbGeAlD
Tamoxifen—DHCR7—central nervous system—acquired immunodeficiency syndrome	0.000531	0.00738	CbGeAlD
Tamoxifen—FMO1—central nervous system—acquired immunodeficiency syndrome	0.000531	0.00738	CbGeAlD
Tamoxifen—ESRRA—central nervous system—acquired immunodeficiency syndrome	0.000523	0.00726	CbGeAlD
Tamoxifen—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000521	0.00723	CbGeAlD
Tamoxifen—FMO3—lung—acquired immunodeficiency syndrome	0.000515	0.00715	CbGeAlD
Tamoxifen—CES1—lymphoid tissue—acquired immunodeficiency syndrome	0.000493	0.00685	CbGeAlD
Tamoxifen—CES1—digestive system—acquired immunodeficiency syndrome	0.000487	0.00676	CbGeAlD
Tamoxifen—FMO3—nervous system—acquired immunodeficiency syndrome	0.000477	0.00662	CbGeAlD
Tamoxifen—CES1—blood—acquired immunodeficiency syndrome	0.000464	0.00644	CbGeAlD
Tamoxifen—FMO3—central nervous system—acquired immunodeficiency syndrome	0.000459	0.00638	CbGeAlD
Tamoxifen—ESR2—lymphoid tissue—acquired immunodeficiency syndrome	0.000427	0.00593	CbGeAlD
Tamoxifen—DHCR7—brain—acquired immunodeficiency syndrome	0.000422	0.00586	CbGeAlD
Tamoxifen—FMO1—brain—acquired immunodeficiency syndrome	0.000422	0.00586	CbGeAlD
Tamoxifen—ESR2—digestive system—acquired immunodeficiency syndrome	0.000421	0.00586	CbGeAlD
Tamoxifen—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000419	0.00582	CbGeAlD
Tamoxifen—ESRRA—brain—acquired immunodeficiency syndrome	0.000415	0.00577	CbGeAlD
Tamoxifen—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000412	0.00573	CbGeAlD
Tamoxifen—DHCR7—lymph node—acquired immunodeficiency syndrome	0.000407	0.00566	CbGeAlD
Tamoxifen—FMO1—lymph node—acquired immunodeficiency syndrome	0.000407	0.00566	CbGeAlD
Tamoxifen—CES1—lung—acquired immunodeficiency syndrome	0.000407	0.00565	CbGeAlD
Tamoxifen—ESR2—blood—acquired immunodeficiency syndrome	0.000402	0.00558	CbGeAlD
Tamoxifen—ESRRA—lymph node—acquired immunodeficiency syndrome	0.000401	0.00557	CbGeAlD
Tamoxifen—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000388	0.00539	CbGeAlD
Tamoxifen—CES1—nervous system—acquired immunodeficiency syndrome	0.000376	0.00523	CbGeAlD
Tamoxifen—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000374	0.0052	CbGeAlD
Tamoxifen—ESR2—vagina—acquired immunodeficiency syndrome	0.000372	0.00517	CbGeAlD
Tamoxifen—FMO3—brain—acquired immunodeficiency syndrome	0.000364	0.00506	CbGeAlD
Tamoxifen—CES1—central nervous system—acquired immunodeficiency syndrome	0.000362	0.00504	CbGeAlD
Tamoxifen—CYP2A6—lung—acquired immunodeficiency syndrome	0.000354	0.00492	CbGeAlD
Tamoxifen—FMO3—lymph node—acquired immunodeficiency syndrome	0.000352	0.00489	CbGeAlD
Tamoxifen—ESR2—lung—acquired immunodeficiency syndrome	0.000352	0.00489	CbGeAlD
Tamoxifen—ESR2—nervous system—acquired immunodeficiency syndrome	0.000326	0.00453	CbGeAlD
Tamoxifen—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000317	0.0044	CbGeAlD
Tamoxifen—CYP19A1—blood—acquired immunodeficiency syndrome	0.000316	0.0044	CbGeAlD
Tamoxifen—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000314	0.00437	CbGeAlD
Tamoxifen—ESR2—central nervous system—acquired immunodeficiency syndrome	0.000314	0.00436	CbGeAlD
Tamoxifen—SIGMAR1—blood—acquired immunodeficiency syndrome	0.000311	0.00432	CbGeAlD
Tamoxifen—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.00031	0.00431	CbGeAlD
Tamoxifen—ABCC2—blood—acquired immunodeficiency syndrome	0.000302	0.0042	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.000301	0.00418	CbGeAlD
Tamoxifen—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.0003	0.00416	CbGeAlD
Tamoxifen—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000296	0.00412	CbGeAlD
Tamoxifen—CYP1B1—blood—acquired immunodeficiency syndrome	0.000296	0.00411	CbGeAlD
Tamoxifen—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.000292	0.00406	CbGeAlD
Tamoxifen—ESR1—digestive system—acquired immunodeficiency syndrome	0.000289	0.00401	CbGeAlD
Tamoxifen—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000288	0.00401	CbGeAlD
Tamoxifen—CES1—brain—acquired immunodeficiency syndrome	0.000288	0.004	CbGeAlD
Tamoxifen—CES1—lymph node—acquired immunodeficiency syndrome	0.000278	0.00386	CbGeAlD
Tamoxifen—ESR1—blood—acquired immunodeficiency syndrome	0.000275	0.00382	CbGeAlD
Tamoxifen—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000274	0.00381	CbGeAlD
Tamoxifen—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000273	0.00379	CbGeAlD
Tamoxifen—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000272	0.00379	CbGeAlD
Tamoxifen—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000267	0.0037	CbGeAlD
Tamoxifen—CYP2C19—blood—acquired immunodeficiency syndrome	0.00026	0.00361	CbGeAlD
Tamoxifen—CYP1B1—lung—acquired immunodeficiency syndrome	0.000259	0.0036	CbGeAlD
Tamoxifen—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000257	0.00357	CbGeAlD
Tamoxifen—ESR1—vagina—acquired immunodeficiency syndrome	0.000255	0.00354	CbGeAlD
Tamoxifen—CYP2A6—brain—acquired immunodeficiency syndrome	0.00025	0.00348	CbGeAlD
Tamoxifen—ESR2—brain—acquired immunodeficiency syndrome	0.000249	0.00346	CbGeAlD
Tamoxifen—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.000247	0.00344	CbGeAlD
Tamoxifen—ESR1—lung—acquired immunodeficiency syndrome	0.000241	0.00335	CbGeAlD
Tamoxifen—ESR2—lymph node—acquired immunodeficiency syndrome	0.000241	0.00334	CbGeAlD
Tamoxifen—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000241	0.00334	CbGeAlD
Tamoxifen—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.00024	0.00334	CbGeAlD
Tamoxifen—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000231	0.00321	CbGeAlD
Tamoxifen—CYP2C8—blood—acquired immunodeficiency syndrome	0.000227	0.00315	CbGeAlD
Tamoxifen—ESR1—nervous system—acquired immunodeficiency syndrome	0.000223	0.0031	CbGeAlD
Tamoxifen—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000223	0.00309	CbGeAlD
Tamoxifen—ABCG2—blood—acquired immunodeficiency syndrome	0.00022	0.00306	CbGeAlD
Tamoxifen—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000219	0.00305	CbGeAlD
Tamoxifen—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000216	0.003	CbGeAlD
Tamoxifen—ESR1—central nervous system—acquired immunodeficiency syndrome	0.000215	0.00299	CbGeAlD
Tamoxifen—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000215	0.00298	CbGeAlD
Tamoxifen—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000213	0.00296	CbGeAlD
Tamoxifen—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000213	0.00296	CbGeAlD
Tamoxifen—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000212	0.00295	CbGeAlD
Tamoxifen—CYP1A2—blood—acquired immunodeficiency syndrome	0.000212	0.00295	CbGeAlD
Tamoxifen—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000211	0.00293	CbGeAlD
Tamoxifen—CYP2C8—vagina—acquired immunodeficiency syndrome	0.00021	0.00292	CbGeAlD
Tamoxifen—CYP1A1—blood—acquired immunodeficiency syndrome	0.000209	0.00291	CbGeAlD
Tamoxifen—CYP3A5—blood—acquired immunodeficiency syndrome	0.000204	0.00284	CbGeAlD
Tamoxifen—ABCG2—vagina—acquired immunodeficiency syndrome	0.000204	0.00284	CbGeAlD
Tamoxifen—CYP2B6—blood—acquired immunodeficiency syndrome	0.000203	0.00282	CbGeAlD
Tamoxifen—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000203	0.00282	CbGeAlD
Tamoxifen—CYP2C9—blood—acquired immunodeficiency syndrome	0.000201	0.0028	CbGeAlD
Tamoxifen—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.0002	0.00278	CbGeAlD
Tamoxifen—CYP19A1—brain—acquired immunodeficiency syndrome	0.000196	0.00273	CbGeAlD
Tamoxifen—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000194	0.00269	CbGeAlD
Tamoxifen—ABCG2—lung—acquired immunodeficiency syndrome	0.000193	0.00268	CbGeAlD
Tamoxifen—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000193	0.00268	CbGeAlD
Tamoxifen—CYP2E1—blood—acquired immunodeficiency syndrome	0.000191	0.00265	CbGeAlD
Tamoxifen—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.00019	0.00264	CbGeAlD
Tamoxifen—CYP3A5—vagina—acquired immunodeficiency syndrome	0.00019	0.00263	CbGeAlD
Tamoxifen—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000188	0.00262	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000187	0.00259	CbGeAlD
Tamoxifen—CYP1A2—lung—acquired immunodeficiency syndrome	0.000186	0.00258	CbGeAlD
Tamoxifen—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000184	0.00255	CbGeAlD
Tamoxifen—CYP1B1—brain—acquired immunodeficiency syndrome	0.000184	0.00255	CbGeAlD
Tamoxifen—CYP1A1—lung—acquired immunodeficiency syndrome	0.000183	0.00255	CbGeAlD
Tamoxifen—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000181	0.00252	CbGeAlD
Tamoxifen—CYP3A5—lung—acquired immunodeficiency syndrome	0.000179	0.00249	CbGeAlD
Tamoxifen—CYP2B6—lung—acquired immunodeficiency syndrome	0.000178	0.00247	CbGeAlD
Tamoxifen—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000177	0.00246	CbGeAlD
Tamoxifen—ESR1—brain—acquired immunodeficiency syndrome	0.000171	0.00237	CbGeAlD
Tamoxifen—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.00017	0.00236	CbGeAlD
Tamoxifen—CYP2E1—lung—acquired immunodeficiency syndrome	0.000167	0.00232	CbGeAlD
Tamoxifen—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000165	0.00229	CbGeAlD
Tamoxifen—ESR1—lymph node—acquired immunodeficiency syndrome	0.000165	0.00229	CbGeAlD
Tamoxifen—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000163	0.00227	CbGeAlD
Tamoxifen—ABCB1—retina—acquired immunodeficiency syndrome	0.000162	0.00226	CbGeAlD
Tamoxifen—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000161	0.00224	CbGeAlD
Tamoxifen—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000159	0.00221	CbGeAlD
Tamoxifen—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000158	0.0022	CbGeAlD
Tamoxifen—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000155	0.00215	CbGeAlD
Tamoxifen—CYP3A4—blood—acquired immunodeficiency syndrome	0.000153	0.00213	CbGeAlD
Tamoxifen—CYP2D6—blood—acquired immunodeficiency syndrome	0.000151	0.0021	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000149	0.00207	CbGeAlD
Tamoxifen—CYP2C8—brain—acquired immunodeficiency syndrome	0.000141	0.00195	CbGeAlD
Tamoxifen—ABCG2—brain—acquired immunodeficiency syndrome	0.000137	0.0019	CbGeAlD
Tamoxifen—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000132	0.00183	CbGeAlD
Tamoxifen—CYP1A1—brain—acquired immunodeficiency syndrome	0.00013	0.0018	CbGeAlD
Tamoxifen—CYP2B6—brain—acquired immunodeficiency syndrome	0.000126	0.00175	CbGeAlD
Tamoxifen—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000125	0.00174	CbGeAlD
Tamoxifen—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000125	0.00173	CbGeAlD
Tamoxifen—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000123	0.0017	CbGeAlD
Tamoxifen—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00012	0.00167	CbGeAlD
Tamoxifen—CYP2E1—brain—acquired immunodeficiency syndrome	0.000118	0.00164	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000118	0.00164	CbGeAlD
Tamoxifen—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000612	CcSEcCtD
Tamoxifen—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000611	CcSEcCtD
Tamoxifen—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.00061	CcSEcCtD
Tamoxifen—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000609	CcSEcCtD
Tamoxifen—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000609	CcSEcCtD
Tamoxifen—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000116	0.000609	CcSEcCtD
Tamoxifen—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000115	0.0016	CbGeAlD
Tamoxifen—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000607	CcSEcCtD
Tamoxifen—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000115	0.000605	CcSEcCtD
Tamoxifen—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000605	CcSEcCtD
Tamoxifen—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000115	0.000603	CcSEcCtD
Tamoxifen—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000603	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000603	CcSEcCtD
Tamoxifen—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000602	CcSEcCtD
Tamoxifen—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000114	0.0006	CcSEcCtD
Tamoxifen—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000114	0.00158	CbGeAlD
Tamoxifen—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000114	0.0006	CcSEcCtD
Tamoxifen—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000599	CcSEcCtD
Tamoxifen—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000599	CcSEcCtD
Tamoxifen—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000599	CcSEcCtD
Tamoxifen—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000596	CcSEcCtD
Tamoxifen—Rash—Didanosine—acquired immunodeficiency syndrome	0.000113	0.000595	CcSEcCtD
Tamoxifen—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000595	CcSEcCtD
Tamoxifen—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000595	CcSEcCtD
Tamoxifen—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000113	0.000594	CcSEcCtD
Tamoxifen—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000113	0.000594	CcSEcCtD
Tamoxifen—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000592	CcSEcCtD
Tamoxifen—Headache—Didanosine—acquired immunodeficiency syndrome	0.000112	0.000591	CcSEcCtD
Tamoxifen—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000112	0.00059	CcSEcCtD
Tamoxifen—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000112	0.000589	CcSEcCtD
Tamoxifen—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000112	0.000588	CcSEcCtD
Tamoxifen—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000586	CcSEcCtD
Tamoxifen—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000586	CcSEcCtD
Tamoxifen—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000584	CcSEcCtD
Tamoxifen—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000583	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000582	CcSEcCtD
Tamoxifen—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.000581	CcSEcCtD
Tamoxifen—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.00058	CcSEcCtD
Tamoxifen—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000579	CcSEcCtD
Tamoxifen—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00011	0.000579	CcSEcCtD
Tamoxifen—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000579	CcSEcCtD
Tamoxifen—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000577	CcSEcCtD
Tamoxifen—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000577	CcSEcCtD
Tamoxifen—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000577	CcSEcCtD
Tamoxifen—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000576	CcSEcCtD
Tamoxifen—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000576	CcSEcCtD
Tamoxifen—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000575	CcSEcCtD
Tamoxifen—ABCB1—blood—acquired immunodeficiency syndrome	0.000109	0.00151	CbGeAlD
Tamoxifen—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000572	CcSEcCtD
Tamoxifen—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000571	CcSEcCtD
Tamoxifen—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000571	CcSEcCtD
Tamoxifen—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000571	CcSEcCtD
Tamoxifen—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.00057	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.00057	CcSEcCtD
Tamoxifen—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00057	CcSEcCtD
Tamoxifen—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000569	CcSEcCtD
Tamoxifen—Pain—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000566	CcSEcCtD
Tamoxifen—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000566	CcSEcCtD
Tamoxifen—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000566	CcSEcCtD
Tamoxifen—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000566	CcSEcCtD
Tamoxifen—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000565	CcSEcCtD
Tamoxifen—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000564	CcSEcCtD
Tamoxifen—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000563	CcSEcCtD
Tamoxifen—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000562	CcSEcCtD
Tamoxifen—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000562	CcSEcCtD
Tamoxifen—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000106	0.00056	CcSEcCtD
Tamoxifen—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000106	0.00056	CcSEcCtD
Tamoxifen—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000558	CcSEcCtD
Tamoxifen—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000557	CcSEcCtD
Tamoxifen—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000556	CcSEcCtD
Tamoxifen—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000556	CcSEcCtD
Tamoxifen—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000556	CcSEcCtD
Tamoxifen—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000554	CcSEcCtD
Tamoxifen—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000553	CcSEcCtD
Tamoxifen—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000105	0.00146	CbGeAlD
Tamoxifen—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000552	CcSEcCtD
Tamoxifen—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000105	0.00145	CbGeAlD
Tamoxifen—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000551	CcSEcCtD
Tamoxifen—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000549	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000545	CcSEcCtD
Tamoxifen—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000544	CcSEcCtD
Tamoxifen—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000543	CcSEcCtD
Tamoxifen—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000543	CcSEcCtD
Tamoxifen—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000543	CcSEcCtD
Tamoxifen—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000542	CcSEcCtD
Tamoxifen—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000542	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000541	CcSEcCtD
Tamoxifen—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000541	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.00054	CcSEcCtD
Tamoxifen—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000539	CcSEcCtD
Tamoxifen—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000539	CcSEcCtD
Tamoxifen—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000537	CcSEcCtD
Tamoxifen—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000535	CcSEcCtD
Tamoxifen—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000535	CcSEcCtD
Tamoxifen—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000535	CcSEcCtD
Tamoxifen—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000535	CcSEcCtD
Tamoxifen—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000534	CcSEcCtD
Tamoxifen—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000534	CcSEcCtD
Tamoxifen—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000534	CcSEcCtD
Tamoxifen—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000533	CcSEcCtD
Tamoxifen—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000101	0.000531	CcSEcCtD
Tamoxifen—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.00053	CcSEcCtD
Tamoxifen—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.00053	CcSEcCtD
Tamoxifen—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.00053	CcSEcCtD
Tamoxifen—ABCB1—vagina—acquired immunodeficiency syndrome	0.000101	0.0014	CbGeAlD
Tamoxifen—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000529	CcSEcCtD
Tamoxifen—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000528	CcSEcCtD
Tamoxifen—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000528	CcSEcCtD
Tamoxifen—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000527	CcSEcCtD
Tamoxifen—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.99e-05	0.000526	CcSEcCtD
Tamoxifen—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.95e-05	0.000524	CcSEcCtD
Tamoxifen—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.94e-05	0.000523	CcSEcCtD
Tamoxifen—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.92e-05	0.000522	CcSEcCtD
Tamoxifen—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000522	CcSEcCtD
Tamoxifen—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.89e-05	0.000521	CcSEcCtD
Tamoxifen—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.88e-05	0.00052	CcSEcCtD
Tamoxifen—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.85e-05	0.000518	CcSEcCtD
Tamoxifen—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.84e-05	0.000518	CcSEcCtD
Tamoxifen—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.83e-05	0.000518	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.82e-05	0.000517	CcSEcCtD
Tamoxifen—Rash—Stavudine—acquired immunodeficiency syndrome	9.81e-05	0.000516	CcSEcCtD
Tamoxifen—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.8e-05	0.000516	CcSEcCtD
Tamoxifen—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.8e-05	0.000516	CcSEcCtD
Tamoxifen—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.78e-05	0.000515	CcSEcCtD
Tamoxifen—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.78e-05	0.000515	CcSEcCtD
Tamoxifen—Headache—Stavudine—acquired immunodeficiency syndrome	9.75e-05	0.000513	CcSEcCtD
Tamoxifen—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.75e-05	0.000513	CcSEcCtD
Tamoxifen—Pain—Delavirdine—acquired immunodeficiency syndrome	9.72e-05	0.000512	CcSEcCtD
Tamoxifen—Constipation—Delavirdine—acquired immunodeficiency syndrome	9.72e-05	0.000512	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	9.72e-05	0.000512	CcSEcCtD
Tamoxifen—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.7e-05	0.000511	CcSEcCtD
Tamoxifen—Rash—Abacavir—acquired immunodeficiency syndrome	9.67e-05	0.000509	CcSEcCtD
Tamoxifen—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.66e-05	0.000508	CcSEcCtD
Tamoxifen—Oedema—Lamivudine—acquired immunodeficiency syndrome	9.66e-05	0.000508	CcSEcCtD
Tamoxifen—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.65e-05	0.000508	CcSEcCtD
Tamoxifen—Headache—Abacavir—acquired immunodeficiency syndrome	9.6e-05	0.000505	CcSEcCtD
Tamoxifen—Infection—Lamivudine—acquired immunodeficiency syndrome	9.59e-05	0.000505	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	9.58e-05	0.000504	CcSEcCtD
Tamoxifen—Nausea—Nevirapine—acquired immunodeficiency syndrome	9.57e-05	0.000504	CcSEcCtD
Tamoxifen—Pruritus—Zidovudine—acquired immunodeficiency syndrome	9.57e-05	0.000504	CcSEcCtD
Tamoxifen—ABCB1—lung—acquired immunodeficiency syndrome	9.52e-05	0.00132	CbGeAlD
Tamoxifen—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.51e-05	0.000501	CcSEcCtD
Tamoxifen—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.45e-05	0.000498	CcSEcCtD
Tamoxifen—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.44e-05	0.000497	CcSEcCtD
Tamoxifen—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.44e-05	0.000497	CcSEcCtD
Tamoxifen—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	9.39e-05	0.000495	CcSEcCtD
Tamoxifen—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	9.37e-05	0.000493	CcSEcCtD
Tamoxifen—CYP2D6—brain—acquired immunodeficiency syndrome	9.37e-05	0.0013	CbGeAlD
Tamoxifen—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.33e-05	0.000491	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.3e-05	0.000489	CcSEcCtD
Tamoxifen—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.27e-05	0.000488	CcSEcCtD
Tamoxifen—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	9.27e-05	0.000488	CcSEcCtD
Tamoxifen—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.000487	CcSEcCtD
Tamoxifen—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.25e-05	0.000487	CcSEcCtD
Tamoxifen—Nausea—Stavudine—acquired immunodeficiency syndrome	9.24e-05	0.000487	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.22e-05	0.000485	CcSEcCtD
Tamoxifen—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.2e-05	0.000484	CcSEcCtD
Tamoxifen—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.15e-05	0.000482	CcSEcCtD
Tamoxifen—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.14e-05	0.000481	CcSEcCtD
Tamoxifen—Nausea—Abacavir—acquired immunodeficiency syndrome	9.11e-05	0.000479	CcSEcCtD
Tamoxifen—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.09e-05	0.000478	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.08e-05	0.000478	CcSEcCtD
Tamoxifen—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.07e-05	0.000477	CcSEcCtD
Tamoxifen—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.03e-05	0.000475	CcSEcCtD
Tamoxifen—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.02e-05	0.000475	CcSEcCtD
Tamoxifen—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.02e-05	0.000475	CcSEcCtD
Tamoxifen—Pain—Ritonavir—acquired immunodeficiency syndrome	8.99e-05	0.000473	CcSEcCtD
Tamoxifen—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.99e-05	0.000473	CcSEcCtD
Tamoxifen—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.99e-05	0.000473	CcSEcCtD
Tamoxifen—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.94e-05	0.000471	CcSEcCtD
Tamoxifen—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000469	CcSEcCtD
Tamoxifen—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.9e-05	0.000468	CcSEcCtD
Tamoxifen—ABCB1—nervous system—acquired immunodeficiency syndrome	8.82e-05	0.00123	CbGeAlD
Tamoxifen—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.8e-05	0.000463	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.8e-05	0.000463	CcSEcCtD
Tamoxifen—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.76e-05	0.000461	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.00046	CcSEcCtD
Tamoxifen—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.73e-05	0.00046	CcSEcCtD
Tamoxifen—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.73e-05	0.000459	CcSEcCtD
Tamoxifen—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.67e-05	0.000456	CcSEcCtD
Tamoxifen—Constipation—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000456	CcSEcCtD
Tamoxifen—Pain—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000456	CcSEcCtD
Tamoxifen—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	8.61e-05	0.000453	CcSEcCtD
Tamoxifen—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.61e-05	0.000453	CcSEcCtD
Tamoxifen—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.6e-05	0.000453	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.6e-05	0.000453	CcSEcCtD
Tamoxifen—Rash—Zidovudine—acquired immunodeficiency syndrome	8.53e-05	0.000449	CcSEcCtD
Tamoxifen—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.53e-05	0.000449	CcSEcCtD
Tamoxifen—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.52e-05	0.000448	CcSEcCtD
Tamoxifen—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.000447	CcSEcCtD
Tamoxifen—ABCB1—central nervous system—acquired immunodeficiency syndrome	8.49e-05	0.00118	CbGeAlD
Tamoxifen—Headache—Zidovudine—acquired immunodeficiency syndrome	8.47e-05	0.000446	CcSEcCtD
Tamoxifen—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.41e-05	0.000443	CcSEcCtD
Tamoxifen—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.39e-05	0.000442	CcSEcCtD
Tamoxifen—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	8.38e-05	0.000441	CcSEcCtD
Tamoxifen—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.35e-05	0.00044	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000439	CcSEcCtD
Tamoxifen—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.32e-05	0.000438	CcSEcCtD
Tamoxifen—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.32e-05	0.000438	CcSEcCtD
Tamoxifen—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.31e-05	0.000438	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.28e-05	0.000436	CcSEcCtD
Tamoxifen—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.26e-05	0.000435	CcSEcCtD
Tamoxifen—Pain—Lamivudine—acquired immunodeficiency syndrome	8.26e-05	0.000435	CcSEcCtD
Tamoxifen—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.16e-05	0.000429	CcSEcCtD
Tamoxifen—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.13e-05	0.000428	CcSEcCtD
Tamoxifen—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.04e-05	0.000423	CcSEcCtD
Tamoxifen—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.04e-05	0.000423	CcSEcCtD
Tamoxifen—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.03e-05	0.000423	CcSEcCtD
Tamoxifen—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.000421	CcSEcCtD
Tamoxifen—Vomiting—Indinavir—acquired immunodeficiency syndrome	8e-05	0.000421	CcSEcCtD
Tamoxifen—Rash—Indinavir—acquired immunodeficiency syndrome	7.93e-05	0.000417	CcSEcCtD
Tamoxifen—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.92e-05	0.000417	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.9e-05	0.000416	CcSEcCtD
Tamoxifen—Headache—Indinavir—acquired immunodeficiency syndrome	7.88e-05	0.000415	CcSEcCtD
Tamoxifen—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.86e-05	0.000414	CcSEcCtD
Tamoxifen—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.78e-05	0.00041	CcSEcCtD
Tamoxifen—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.75e-05	0.000408	CcSEcCtD
Tamoxifen—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.67e-05	0.000404	CcSEcCtD
Tamoxifen—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.63e-05	0.000402	CcSEcCtD
Tamoxifen—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.56e-05	0.000398	CcSEcCtD
Tamoxifen—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.54e-05	0.000397	CcSEcCtD
Tamoxifen—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.52e-05	0.000396	CcSEcCtD
Tamoxifen—Rash—Efavirenz—acquired immunodeficiency syndrome	7.49e-05	0.000394	CcSEcCtD
Tamoxifen—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.49e-05	0.000394	CcSEcCtD
Tamoxifen—Nausea—Indinavir—acquired immunodeficiency syndrome	7.47e-05	0.000393	CcSEcCtD
Tamoxifen—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.46e-05	0.000392	CcSEcCtD
Tamoxifen—Headache—Efavirenz—acquired immunodeficiency syndrome	7.45e-05	0.000392	CcSEcCtD
Tamoxifen—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.44e-05	0.000392	CcSEcCtD
Tamoxifen—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.26e-05	0.000382	CcSEcCtD
Tamoxifen—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.23e-05	0.000381	CcSEcCtD
Tamoxifen—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.19e-05	0.000379	CcSEcCtD
Tamoxifen—Rash—Delavirdine—acquired immunodeficiency syndrome	7.17e-05	0.000377	CcSEcCtD
Tamoxifen—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.16e-05	0.000377	CcSEcCtD
Tamoxifen—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.16e-05	0.000377	CcSEcCtD
Tamoxifen—Headache—Delavirdine—acquired immunodeficiency syndrome	7.12e-05	0.000375	CcSEcCtD
Tamoxifen—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000374	CcSEcCtD
Tamoxifen—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.06e-05	0.000372	CcSEcCtD
Tamoxifen—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.95e-05	0.000366	CcSEcCtD
Tamoxifen—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.93e-05	0.000365	CcSEcCtD
Tamoxifen—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.92e-05	0.000364	CcSEcCtD
Tamoxifen—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.83e-05	0.00036	CcSEcCtD
Tamoxifen—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.75e-05	0.000356	CcSEcCtD
Tamoxifen—ABCB1—brain—acquired immunodeficiency syndrome	6.74e-05	0.000936	CbGeAlD
Tamoxifen—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.69e-05	0.000352	CcSEcCtD
Tamoxifen—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.69e-05	0.000352	CcSEcCtD
Tamoxifen—Rash—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000349	CcSEcCtD
Tamoxifen—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.62e-05	0.000349	CcSEcCtD
Tamoxifen—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.61e-05	0.000348	CcSEcCtD
Tamoxifen—Headache—Ritonavir—acquired immunodeficiency syndrome	6.59e-05	0.000347	CcSEcCtD
Tamoxifen—ABCB1—lymph node—acquired immunodeficiency syndrome	6.51e-05	0.000905	CbGeAlD
Tamoxifen—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.43e-05	0.000339	CcSEcCtD
Tamoxifen—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.38e-05	0.000336	CcSEcCtD
Tamoxifen—Rash—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000336	CcSEcCtD
Tamoxifen—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000336	CcSEcCtD
Tamoxifen—Headache—Saquinavir—acquired immunodeficiency syndrome	6.34e-05	0.000334	CcSEcCtD
Tamoxifen—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.25e-05	0.000329	CcSEcCtD
Tamoxifen—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.14e-05	0.000323	CcSEcCtD
Tamoxifen—Rash—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.00032	CcSEcCtD
Tamoxifen—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.08e-05	0.00032	CcSEcCtD
Tamoxifen—Headache—Lamivudine—acquired immunodeficiency syndrome	6.05e-05	0.000318	CcSEcCtD
Tamoxifen—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.01e-05	0.000316	CcSEcCtD
Tamoxifen—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.73e-05	0.000302	CcSEcCtD
